E Piana

753 total citations
28 papers, 592 citations indexed

About

E Piana is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, E Piana has authored 28 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in E Piana's work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Research Studies (6 papers). E Piana is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Research Studies (6 papers). E Piana collaborates with scholars based in Italy and United States. E Piana's co-authors include Andrea Martoni, F Pannuti, Carmine Pinto, Francesca Di Fabio, S. Giaquinta, Fabiola Lorena Rojas Llimpe, V. Mutri, Claudio Ceccarelli, Stefano Cascinu and Salvatore Siena and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E Piana

27 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Piana Italy 11 390 340 109 102 67 28 592
M. Castiglione Switzerland 7 226 0.6× 186 0.5× 86 0.8× 47 0.5× 37 0.6× 11 359
M. Wenczl Hungary 6 423 1.1× 557 1.6× 198 1.8× 30 0.3× 63 0.9× 15 705
Rakesh Chopra India 8 224 0.6× 164 0.5× 133 1.2× 57 0.6× 48 0.7× 14 558
K. Beerblock France 10 404 1.0× 134 0.4× 75 0.7× 41 0.4× 53 0.8× 22 532
M. Lorenz Germany 8 421 1.1× 228 0.7× 143 1.3× 13 0.1× 73 1.1× 20 620
H. E. Reis Germany 7 201 0.5× 289 0.8× 183 1.7× 60 0.6× 36 0.5× 20 479
D D’Amico Italy 8 158 0.4× 95 0.3× 156 1.4× 38 0.4× 90 1.3× 17 433
Nick Maisey United Kingdom 9 347 0.9× 272 0.8× 313 2.9× 25 0.2× 113 1.7× 16 796
E. Woods United Kingdom 9 247 0.6× 123 0.4× 98 0.9× 22 0.2× 23 0.3× 12 507
Mao-Chih Hsieh Taiwan 16 181 0.5× 453 1.3× 342 3.1× 37 0.4× 69 1.0× 29 752

Countries citing papers authored by E Piana

Since Specialization
Citations

This map shows the geographic impact of E Piana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Piana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Piana more than expected).

Fields of papers citing papers by E Piana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Piana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Piana. The network helps show where E Piana may publish in the future.

Co-authorship network of co-authors of E Piana

This figure shows the co-authorship network connecting the top 25 collaborators of E Piana. A scholar is included among the top collaborators of E Piana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Piana. E Piana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martoni, Andrea, Barbara Melotti, Francesca Sperandi, et al.. (2008). Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study. Lung Cancer. 60(3). 387–392. 7 indexed citations
2.
3.
Pinto, Carmine, Francesca Di Fabio, Salvatore Siena, et al.. (2006). Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Annals of Oncology. 18(3). 510–517. 223 indexed citations
4.
Pinto, Carmine, Antonella Marino, Vincenzo de Pangher Manzini, et al.. (2006). Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. Lung Cancer. 52(2). 199–206. 7 indexed citations
5.
Pinto, Carmine, Francesca Di Fabio, Salvatore Siena, et al.. (2006). Phase II study of cetuximab plus FOLFIRI as first-line treatment in patients with unresectable/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (FOLCETUX study): Preliminary results. Journal of Clinical Oncology. 24(18_suppl). 4031–4031. 9 indexed citations
6.
7.
Martoni, Andrea, Enrico Mini, Carmine Pinto, et al.. (2001). Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma. Annals of Oncology. 12(4). 519–524. 18 indexed citations
8.
Martoni, Andrea, Francesca Di Fabio, M. Guaraldi, et al.. (2001). Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 24(6). 614–617. 33 indexed citations
9.
Pinto, Carmine, Antonella Marino, M. Guaraldi, et al.. (2001). Combination Chemotherapy With Mitoxantrone, Methotrexate, and Mitomycin (MMM Regimen) in Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 24(2). 143–147. 23 indexed citations
10.
Martoni, Andrea, M. Guaraldi, & E Piana. (1999). Anthracyclines in non-small-cell lung cancer: Do they have a therapeutic role?. Annals of Oncology. 10. S19–S23. 5 indexed citations
11.
Martoni, Andrea, M. Guaraldi, E Piana, et al.. (1998). Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer. 22(1). 31–38. 25 indexed citations
12.
13.
Martoni, Andrea, et al.. (1990). Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer. Oncology. 47(5). 427–432. 24 indexed citations
14.
Pannuti, F, Alessandra Longhi, Andrea Martoni, E Piana, & María V. Baroni. (1987). Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.. PubMed. 6(2 Suppl). 396–8. 3 indexed citations
15.
Martoni, Andrea, et al.. (1986). A pilot study of oral idarubicin in metastatic melanoma.. PubMed. 5(6). 414–5. 4 indexed citations
16.
Pannuti, F, et al.. (1985). Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.. PubMed. 4(2). 127–34. 4 indexed citations
17.
Pannuti, F, et al.. (1981). Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology.. PubMed. 22(3). 149–56. 2 indexed citations
18.
Pannuti, F, Andrea Martoni, E Piana, et al.. (1979). Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer. European Journal of Cancer (1965). 15(4). 593–601. 61 indexed citations
19.
Pannuti, F, et al.. (1978). A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.. PubMed. 62(4). 499–504. 56 indexed citations
20.
Sala, Giovanni Battista La, et al.. (1978). Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results.. PubMed. 6(4). 129–129. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Castiglione Breakdown of academic impact, for papers by M. Wenczl Breakdown of academic impact, for papers by Rakesh Chopra Breakdown of academic impact, for papers by K. Beerblock Breakdown of academic impact, for papers by M. Lorenz Breakdown of academic impact, for papers by H. E. Reis Breakdown of academic impact, for papers by D D’Amico Breakdown of academic impact, for papers by Nick Maisey Breakdown of academic impact, for papers by E. Woods Breakdown of academic impact, for papers by Mao-Chih Hsieh
Rankless by CCL
2026